USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
VERACHEM, LLC
Address:
P.O. Box 2206
GERMANTOWN, MD
Phone:
(240) 686-0565
URL:
N/A
EIN:
522201914
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $289,853.00 2
SBIR Phase II $4,151,965.00 2
STTR Phase I $100,000.00 2
STTR Phase II $2,073,798.00 1

Award List:

N/A

Award Year / Program / Phase:
2000 / STTR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Research Institution:
Center for Advanced Research in Biotech
RI Contact:
N/A
Abstract:
N/a

INEXPENSIVE INTERACTIVE MOLECULAR MODELING SOFTWARE

Award Year / Program / Phase:
2002 / STTR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
RI Contact:
N/A
Abstract:
Today, promising new protein targets for small molecule drugs are being discovered rapid. With increasing frequency, the 3D structures of these proteins are available or can be modeled from known protein structures. Demand is therefor growing for software to support structure-based discovery of… More

Software for Accurate Ligand-Protein Affinities

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$149,051.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Discovering a compound that will bind a protein therapeutic target with high affinity, while retaining favorable pharmacological properties, can be a time-consuming and expensive bottleneck in the drug-discovery process. Computational methods can speed this… More

Software for Accurate Ligand-Protein Affinities

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$1,980,527.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Discovering a compound that will bind a protein therapeutic target with high affinity, while retaining favorable pharmacological properties, can be a time-consuming and expensive bottleneck in the drug-discovery process. Computational methods can speed this… More

Multilevel Parallelization of Software for Accurate Protein-Ligand Affinities

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$140,802.00
Agency:
HHS
Principal Investigator:
Simon Webb
Abstract:
DESCRIPTION (provided by applicant): Many drugs are small molecules that act by binding to a specific protein and thus blocking or altering its actions. For example, the HIV protease inhibitors are important AIDS treatments that work by binding in the acti ve site of the protease enzyme and… More

Multilevel Parallelization of Software for Accurate Protein-Ligand Affinities

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,171,438.00
Agency:
HHS
Principal Investigator:
Simon Webb – 240-686-0565
Abstract:
DESCRIPTION (provided by applicant): Many drugs are small molecules that act by binding to a specific protein and thus blocking or altering its actions. For example, the HIV protease inhibitors are important AIDS treatments that work by binding in the active site of the protease enzyme and… More